End Cash (Quarterly)

End Cash: The amount of cash held by the company for the given period.

DarioHealth Corp. (DRIO) had End Cash of $31.91M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$5.01M
Net Income	$-18.86M
Cost of Goods Sold	$1.99M
Gross Profit	$3.02M
Operating Expenses	$14.49M
Operating Income	$-9.48M
Non-Operating Income/Expense	$-0.98M
Pre-Tax Income	$-10.47M
Normalized Pre-Tax Income	$-10.47M
Income after Taxes	$-10.47M
Income from Continuous Operations	$-10.47M
Consolidated Net Income/Loss	$-10.47M
Normalized Income after Taxes	$-10.47M
EBIT	$-9.48M
EBITDA	$-8.62M
Weighted-Average Shares Outstanding (Basic)	3.14M
Weighted-Average Shares Outstanding (Diluted)	3.14M
Earnings per Share (EPS) (Basic)	$-2.96
Earnings per Share (EPS) (Diluted)	$-2.96
Balance Sheet Financials
Current Assets	$42.19M
Property, Plant, and Equipment	$0.58M
Long-Term Assets	$75.54M
Total Assets	$117.73M
Current Liabilities	$9.28M
Long-Term Debt	$30.62M
Long-Term Liabilities	$33.51M
Total Liabilities	$42.79M
Common Equity	$74.93M
Tangible Shareholders Equity	$1.10M
Shareholders Equity	$74.93M
Common Shares Outstanding	6.77M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-20.05M
Cash Flow from Investing Activities	$-0.12M
Cash Flow from Financial Activities	$24.33M
Beginning Cash	$27.76M
End Cash	$31.91M
Increase/Decrease in Cash	$4.14M
Stock-Based Compensation	$7.33M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.55
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.29
Debt to Equity Ratio	0.41
Gross Margin	60.22%
Operating Margin	-189.41%
EBIT Margin	-189.41%
EBITDA Margin	--
Pre-Tax Profit Margin	-209.03%
Profit Margin	-376.57%
Free Cash Flow	$-20.17M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.04
Inventory Turnover	0.41
Receiveable Turnover	0.97
Days Sales in Receivables	93.24
Return on Equity	-13.97%
Return on Tangible Equity	-949.73%
Return on Assets	-8.89%
Return on Investments	-9.92%
Book Value Per Share	$11.07
Free Cash Flow per Share	$-6.43
Operating Cash Flow per Share	$-6.39

Data from Zacks Investment Research, Inc.